11.09.2021 - 11.10.2021
|
Speaking Engagements
Sponsorship
American Conference Institute (ACI) / New York, NY
About Us
中文网站
Offices
Careers
Client Advantage
Client Login
11.09.2021 - 11.10.2021
|
Speaking Engagements
Sponsorship
American Conference Institute (ACI) / New York, NY
Perkins Coie sponsored the ACI 16th Annual Paragraph IV Disputes Conference which was held November 9 -10 in New York. Partner David Anstaett, along with others, presented on “Written Description and Enablement: Defensive Strategies and Offensive Moves for §112 Rejections and Attacks” on November 10. Click here for additional event details and full agenda.
11.10.2021
In one of the most important patent stories of the year, the Federal Circuit issued a groundbreaking decision concerning the validity of antibody epitome claims covering a reference product. In Amgen Inc. v. Sanofi, No. 20-1074 (Fed. Cir. 2021), the court held that “a genus of antibodies claimed only by specific functional properties are invalid for lack of enablement.” The Federal Circuit invalidated all claims for lack of enablement, holding that “the binding limitation itself was sufficient for the claims to require undue experimentation.” In view of this precedential decision, this panel will consider the new requirements for creating a valid patent and how best to leverage recent decisions.
We use cookies on this website to enhance your user experience and to improve the quality of our site. By continuing to use this website, you are demonstrating your consent to the placement and use of cookies as described in our Cookie Policy.